Buy & Sell Five Below Inc (FIVE) – Five Below Inc Price Today
Aura AI Summary
Key Stats
- $11.81BMarket Cap
- Consumer StaplesSector
- -15.97%3M Drawdown
- $12.91BEnterprise Value
- -Dividend Yield
- 44 daysTypical Hold Time
Five Below Inc (FIVE) is currently valued at a market capitalization of $11.81B, with an enterprise value of $12.91B. Over the past 52 weeks, Five Below Inc has traded between a low of $107.27 and a high of $247.71, highlighting its annual price range. Over the past three months, Five Below Inc has recorded a drawdown of -15.97%, reflecting recent price volatility. On average, investors hold Five Below Inc for approximately 44 days, indicating typical investor behavior on the platform.
About Five Below Inc
Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Most Recent News
Vuzix showcases advanced waveguide smart glasses for defense at SOF Week 2026 in Florida
Vuzix Corporation is exhibiting its advanced AI-powered smart glasses and waveguide solutions at SOF Week 2026 in Tampa, Florida. These products are designed for defense use, offering mission-ready optical performance in challenging environments, inc...

Over 50 companies advance 55+ new pulmonary arterial hypertension drugs in clinical trials.
More than 50 companies are actively developing over 55 new drugs for pulmonary arterial hypertension (PAH), a serious lung-related heart condition. These drugs are in various clinical trial stages, with several in late-stage development, aiming to im...

ANKTIVA combo shows higher response rates and fewer side effects vs rival bladder cancer therapies
ImmunityBio presented data showing its ANKTIVA plus BCG treatment outperformed two FDA-approved bladder cancer therapies, Adstiladrin and INLEXZO. The ANKTIVA combo achieved a 69.7% complete response rate versus 53.4% for Adstiladrin, with a longer m...
